Drugs Used For Coagulation Disorders Flashcards
(56 cards)
What anticlotting drugs are classified as Anticoagulants?
Heparins
Direct Thrombin Inhibitors
Direct Factor Xa inhibitors
Warfarin
What anticlotting drugs are classified as thrombolytics?
t-PA Derivatives
Aminocaproic Acid
What anticlotting drugs are classified as antiplatelet drugs?
Asprin
Gp IIb/IIIa inhibitors
ADP inhibitors (clopidogrel)
PDE/adenosine uptake inhibitors
What drugs are COX inhibitors?
• Drug Sub-Class of Clotting Drug
• MOA
Antiplatelet Drugs
• ASPRIN (irreversible)
• Ibuprofen (reversible)
MOA:
• Asprin inhibits COX-1 and prevents TXA2 from being formed
What drugs are ADP P2Y212 inhibitors?
• Drug Sub-Class of Clotting Drug
• MOA
Antiplatelet Drugs
• CLOPIDOGREL (preferred agent)
• TICLOPIDINE
• Prasugrel
MOA:
• Block the effects of ADP by blocking its receptor (P2Y212)
What drugs are Phosphodiesterase inhibitors
• Drug Sub-Class of Clotting Drug
• MOA
Antiplatelet Drugs
• Dipyridamole
MOA:
• Blocks hydrolysis of cyclic nucleotides like cAMP and cGMP
What drugs are GpIIb/IIIa inhibitors
• Drug Sub-Class of Clotting Drug
• MOA
Antiplatelet Drugs
• ABCIXIMAB
• EFTIBATIDE
• Tirofiban
MOA:
• Blocks binding of fibrinogen to the GpIIb/IIIa receptor, thus preventing platelet AGGREGATION
What drugs are PAR-1 inhibitors
• Drug Sub-Class of Clotting Drug
•MOA
Antiplatelet Drugs
• Vorapaxar
MOA:
• Blocks TXA2 RECEPTOR (PAR-1)
What happens when GPIIb/IIIa binds to fibrinogen?
• What is the GPIIb/IIIa conformational change dependent on?
- Conformational Change to HIGH AFF. Depends on Ca2+
- GPIIb/IIIa binds Fibrinogen - sends signal to platelets
- Platelet then Binds harder in an IRREVERSIBLE manner
Who shouldn’t use platelet inhibiting drugs?
• Anyone at a high risk of bleeding or that may undergo elective surgery soon
***Make sure you give a sufficient amount of time when you discontinue the drug for its effects to dissipate
Asprin***
• Why is it so specific for platelets?
• Is increased dosing ever necessary?
Asprin:
• Blocks COX-1 which is present in many cells and produces PGI2 (a platelet inhibitor) and TXA2 (a platelet aggregant)
- At low doses ENDOTHELIAL cells which make mostly PGI2 can compensate and upreulate COX-1 activity
- Platelets have NO NUCLEUS so no upregulation of COX-1 can happen and TXA2 ceases to be produced
Increased Dose:
• NOT NECESSARY, it will start to inhibit COX2
Asprin***
• Organs typically affected by dose-related toxicity
• Weird Adverse Effects
Organs
• GI tract causing potential for Bleeding and Perforation
• Hepatic and Renal function affected in OD
Weird Effects:
• In some ppl. Asprin induces bronchospasm
Clopidogrel***
• MOA
FIRST LINE therapy in hearth attack and stroke
MOA
• Binds to ADP Receptor (P2Y212) and prevents the GPCR associated Adenylyl Cyclase from getting deactivated
• High levels of cAMP PREVENT platelet conformational changes
Ticlopidine***
• MOA
SECOND LINE therapy in heart attack and stroke
MOA
• Binds to ADP Receptor (P2Y212) and prevents the GPCR associated Adenylyl Cyclase from getting deactivated
• High levels of cAMP PREVENT platelet conformational changes
Dipyridamole
used in heart attack and stroke
MOA
• Binds to ADP Receptor (P2Y212) and prevents the GPCR associated Adenylyl Cyclase from getting deactivated
• High levels of cAMP PREVENT platelet conformational changes
Between the 3 drugs (clopidogrel, Ticlopidinek and Prasugrel) which are pro-drugs?
• How are these drugs given?
• Which shows the greatest variability in metabolism?
Pro-Drugs:
• Clopidogrel**
• Prasugrel
Active Drug:
• Ticlopidinek**- still gets activated to an even more active form.
Administration:
Oral
Variability:
Clopidogrel shows the greastest variability because of CYP2C19 polymorphisms
**Of the P2Y212 inhibitors, which has the most side effects?
• What are these effects?
• Name all of the inhibitors
Ticlopidinek** - SEVERE HEMATOLOGIC SIDE EFFECTS
• Agraulocytosis, Neutropenia
• **THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
• Anemia, Thrombocytopenia
All: Clopdigrel, Ticlopidinek, Prasugrel
Dipyridamole
• Use
• MOA
• Adverse Effects
Use:
• Prevention of Thrombosis in ppl. with prosthetic heart valves
MOA:
• Blocks Phosphodiesterase and causes elevated cAMP which has 2 effects
1. High cAMP prevents Arachiodonic Acid release
2. High cAMP prevents changes in platelet conformation
Adverse Effects:
• Not Remarkable
Abciximab***
MOA
MOA
Bind GPIIa/IIIb and prevent fibrogen from binding
**Abciximab is a MONOCLONAL Ab. and binds the to Arg-Gly-Asp sequence
Eftibatide***
MOA
Bind GPIIa/IIIb and prevent fibrogen from binding
**Derived from snake venom and binds Lys-Gly-Asp but is NOT an Ab.
Tirofiban
MOA
Bind GPIIa/IIIb and prevent fibrogen from binding
**IS NOT an Ab. but binds the to Arg-Gly-Asp sequence
Explain the descrepancy in duration of action between the 3 drugs that bind GPIIa/IIIb.
• Name all of the drugs
Abciximab** is a MONOCLONAL Ab. so its action last for WEEKS (2 wks)
• Effects of Eptifibatide** and Tirofiban cease after only 4 hrs
What are some adverse effects (other than increased bleeding) that may result from the 3 GpIIa/IIIb inhibitors?
• Name these drugs
Abciximab, Eptifibatide, Tirofiban
*Low risk of Anaphylaxis (all 3)
• ABCIXIMAB –> Thrombocytopenia
Vorapaxar
MOA
Major Adverse Effects
MOA:
PAR-1 (protease activated receptor) antagonis
Major Adverse Effects:
VERY LONG HALF LIFE so it acts as though its irreversible and puts you at a VERY HIGH RISK OF BLEEDING